InfuSystem Holdings Inc
F:1TZ
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.2
9.75
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
InfuSystem Holdings Inc
InfuSystem Holdings Inc
Total Current Liabilities
InfuSystem Holdings Inc
Total Current Liabilities Peer Comparison
DVA
DGX
CVS
CI
LH
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
InfuSystem Holdings Inc
F:1TZ
|
Total Current Liabilities
$15.9m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
4%
|
|
|
DaVita Inc
NYSE:DVA
|
Total Current Liabilities
$3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
1%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Total Current Liabilities
$2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
1%
|
CAGR 10-Years
5%
|
|
|
CVS Health Corp
NYSE:CVS
|
Total Current Liabilities
$81.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
17%
|
|
|
Cigna Corp
NYSE:CI
|
Total Current Liabilities
$55.4B
|
CAGR 3-Years
24%
|
CAGR 5-Years
17%
|
CAGR 10-Years
21%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Total Current Liabilities
$4.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
10%
|
CAGR 10-Years
19%
|
See Also
What is InfuSystem Holdings Inc's Total Current Liabilities?
Total Current Liabilities
15.9m
USD
Based on the financial report for Jun 30, 2024, InfuSystem Holdings Inc's Total Current Liabilities amounts to 15.9m USD.
What is InfuSystem Holdings Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
4%
Over the last year, the Total Current Liabilities growth was 23%.
You don't have any saved screeners yet
